
Brunei Tweaks Bridgewater Bet to a Lucrative 20% Stake in Firm
The Brunei Investment Agency is the latest longstanding client to buy a piece of the firm founded by Ray Dalio, which managed $92 billion as of Dec. 31.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
US licenses Nvidia to export chips to China after CEO meets Trump, FT reports
(Reuters) -The U.S. has licensed AI chip bellwether Nvidia to export some chips to China after CEO Jensen Huang met with President Donald Trump, the Financial Times reported on Friday. Sign in to access your portfolio
Yahoo
5 minutes ago
- Yahoo
David Abrams Reduces Stake in Loar Holdings Inc, Impacting Portfolio by -6.74%
Insight into Abrams Capital Management's Latest Moves David Abrams (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. David Abrams (Trades, Portfolio) founded Abrams Capital Management in 1999, where he is the CEO and portfolio manager. Before establishing the Boston-based firm, he worked with Bauposts Seth Klarman (Trades, Portfolio) for 10 years. Describing itself as "opportunistic," Abrams Capital Management follows a fundamental, value-oriented approach to investing. The firm relies on a value approach that emphasizes a company's fundamentals to stocks. It typically invests for the long term in a concentrated number of holdings, spreading its assets across stocks, debt instruments, distressed debt, and illiquid investments, among other classes. Warning! GuruFocus has detected 3 Warning Sign with LOAR. Summary of New Buy David Abrams (Trades, Portfolio) added a total of 1 stock, among them: The most significant addition was Circle Internet Group Inc (NYSE:CRCL), with 275,000 shares, accounting for 0.82% of the portfolio and a total value of $49.85 million. Summary of Sold Out David Abrams (Trades, Portfolio) completely exited 1 of the holdings in the second quarter of 2025, as detailed below: Cantaloupe Inc (NASDAQ:CTLP): David Abrams (Trades, Portfolio) sold all 7,180,000 shares, resulting in a -1% impact on the portfolio. Key Position Reduces David Abrams (Trades, Portfolio) also reduced his position in 1 stock. The most significant changes include: Reduced Loar Holdings Inc (NYSE:LOAR) by 5,377,677 shares, resulting in a -14.37% decrease in shares and a -6.74% impact on the portfolio. The stock traded at an average price of $86.3 during the quarter and has returned -30.13% over the past 3 months and -8.51% year-to-date. Portfolio Overview At the second quarter of 2025, David Abrams (Trades, Portfolio)'s portfolio included 13 stocks, with top holdings including 45.17% in Loar Holdings Inc (NYSE:LOAR), 13.51% in Lithia Motors Inc (NYSE:LAD), 8.23% in Asbury Automotive Group Inc (NYSE:ABG), 6.51% in Somnigroup International Inc (NYSE:SGI), and 6.38% in Coupang Inc (NYSE:CPNG). The holdings are mainly concentrated in 6 of all the 11 industries: Industrials, Consumer Cyclical, Communication Services, Financial Services, Energy, and Healthcare. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Yahoo
5 minutes ago
- Yahoo
Yeo Hiap Seng First Half 2025 Earnings: EPS: S$0.25 (vs S$0.52 in 1H 2024)
Explore Yeo Hiap Seng's Fair Values from the Community and select yours Yeo Hiap Seng (SGX:Y03) First Half 2025 Results Key Financial Results Revenue: S$148.6m (down 10% from 1H 2024). Net income: S$1.58m (down 51% from 1H 2024). Profit margin: 1.1% (down from 1.9% in 1H 2024). The decrease in margin was driven by lower revenue. EPS: S$0.25 (down from S$0.52 in 1H 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Yeo Hiap Seng's share price is broadly unchanged from a week ago. Risk Analysis Be aware that Yeo Hiap Seng is showing 1 warning sign in our investment analysis that you should know about... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.